|
|
|
|
|
BioClever
|
|
Clinical Research in Spain
|
|
This whitepaper is on clinical research in Spain, giving a general outline of the main characteristics of research in this country and an overview of the applicable regulations, along with the reasons why Spain is a good place to do research.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Janssen Announces Phase 1 Results for Bispecific Antibody Amivantamab in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer Harbouring Exon 20 Insertion Mutations
The Janssen Pharmaceutical Companies of Johnson & Johnson today
announced results from the Phase 1 CHRYSALIS study evaluating
amivantamab (JNJ-6372) in the treatment of patients with advanced
non-small cell lung cancer (NSCLC) with epidermal growth factor receptor
(EGFR) Exon 20 insertion mutations. Amivantamab is an EGFR and
MET-targeted bispecific antibody, which targets activating and
resistance EGFR mutations, and MET pathway activation.
More info >> |
|
 |
White Papers |
 |
|
 |
Industry Events |
 |
Clinical Operations in Oncology Trials West Coast
17-18 November 2020, Hilton San Francisco Airport Bayfront
Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >> |
|
|
|
